Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells

Fig. 6

The effect of Nano-PTC209 on the production of reactive oxygen species (ROS) in glioblastoma stem-like cells (GSCs) and U87MG (U87). Nano-PTC209-mediated ROS generation in GSCs and U87 cells was determined using H2DCFDA, which is a fluorescent reagent to detect ROS in cells. ROS induction in the GSCs and U87 cells following Nano-PTC209 treatment was detected by measuring fluorescent intensities in a microplate reader at 4, 8, and 24 h. Data are presented as the mean ± SD. * and *** indicate P < 0.05 and P < 0.001, respectively

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us